RecruitingPhase 2NCT07561294
A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1982 to Prevent Lyme Disease in Healthy Participants (18 to 70 Years of Age)
Studying Lyme disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- ModernaTX, Inc.
- Intervention
- mRNA-1982(biological)
- Enrollment
- 350 target
- Eligibility
- 18-70 years · All sexes
- Timeline
- 2026 – 2028
Study locations (8)
- Colchester Research Group, Truro, Nova Scotia, Canada
- Bluewater Clinical Research Group Inc., Sarnia, Ontario, Canada
- Stouffville Medical Research Institute Inc., Stouffville, Ontario, Canada
- Dr. Anil K. Gupta Medicine Professional Corporation Inc., Toronto, Ontario, Canada
- Diex Recherche Inc. - Division Joliette, Joliette, Quebec, Canada
- Diex Recherche Inc. - Division Sherbrooke, Sherbrooke, Quebec, Canada
- Diex Recherche Inc. - Division Victoriaville, Victoriaville, Quebec, Canada
- Diex Recherche Inc. - Division Quebec, Québec, Canada
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07561294 on ClinicalTrials.govOther trials for Lyme disease
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT07500506A Study to Learn About the Safety, Tolerability, and Immunogenicity of a Fifth Dose of 6-Valent OspA-Based Lyme Disease VaccinePfizer
- RECRUITINGPHASE2NCT07562087A Study to Evaluate Safety and Efficacy of TP-05 in Healthy Participants With Tick ExposureTarsus Pharmaceuticals, Inc.
- RECRUITINGPHASE1, PHASE2NCT06785402Ceftriaxone for Post-Treatment Lyme DiseaseHackensack Meridian Health
- ACTIVE NOT RECRUITINGPHASE3NCT07226882A Study to Learn About Different Dosing Schedules of a Lyme Disease Vaccine in Healthy AdultsPfizer
- RECRUITINGPHASE4NCT06451913Effect of Saccharomyces Boulardii CNCM I-745 on Gut Microbiota in Patients Undergoing Antibiotic Therapy (in the Context of Erythema Migrans (Early Skin Form of Lyme Borreliosis))Biocodex
- RECRUITINGNANCT06915324Transcranial Direct Current Stimulation for Post Treatment Lyme DiseaseColumbia University
- RECRUITINGEARLY PHASE1NCT06611111Ceftriaxone Pulse Dose for Post-Treatment Lyme DiseaseState University of New York - Upstate Medical University
- ACTIVE NOT RECRUITINGNCT06835075Clinicaly Manifested Reinfections with Borrelia Burgdorferi Sensu LatoUniversity Medical Centre Ljubljana